BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33794228)

  • 1. APOL1 at 10 years: progress and next steps.
    Freedman BI; Kopp JB; Sampson MG; Susztak K
    Kidney Int; 2021 Jun; 99(6):1296-1302. PubMed ID: 33794228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background.
    Lannon H; Shah SS; Dias L; Blackler D; Alper SL; Pollak MR; Friedman DJ
    Kidney Int; 2019 Dec; 96(6):1303-1307. PubMed ID: 31611067
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Friedman DJ; Pollak MR
    Annu Rev Physiol; 2020 Feb; 82():323-342. PubMed ID: 31710572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein L1 and mechanisms of kidney disease susceptibility.
    Bruggeman LA; Sedor JR; O'Toole JF
    Curr Opin Nephrol Hypertens; 2021 May; 30(3):317-323. PubMed ID: 33767059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Brief History of APOL1: A Gene Evolving.
    Friedman DJ
    Semin Nephrol; 2017 Nov; 37(6):508-513. PubMed ID: 29110757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOL1 Nephropathy: From Genetics to Clinical Applications.
    Friedman DJ; Pollak MR
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):294-303. PubMed ID: 32616495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOL1 nephropathy - a population genetics success story.
    Tabachnikov O; Skorecki K; Kruzel-Davila E
    Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):447-455. PubMed ID: 38415700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.
    Daneshpajouhnejad P; Kopp JB; Winkler CA; Rosenberg AZ
    Nat Rev Nephrol; 2022 May; 18(5):307-320. PubMed ID: 35217848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment potential in APOL1-associated nephropathy.
    Friedman DJ; Ma L; Freedman BI
    Curr Opin Nephrol Hypertens; 2022 Sep; 31(5):442-448. PubMed ID: 35894278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
    Freedman BI; Limou S; Ma L; Kopp JB
    Am J Kidney Dis; 2018 Nov; 72(5 Suppl 1):S8-S16. PubMed ID: 30343724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOL1 Nephrotoxicity: What Does Ion Transport Have to Do With It?
    Olabisi OA; Heneghan JF
    Semin Nephrol; 2017 Nov; 37(6):546-551. PubMed ID: 29110762
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Cooper A; Ilboudo H; Alibu VP; Ravel S; Enyaru J; Weir W; Noyes H; Capewell P; Camara M; Milet J; Jamonneau V; Camara O; Matovu E; Bucheton B; MacLeod A
    Elife; 2017 May; 6():. PubMed ID: 28537557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.
    Kopp JB; Rosenberg AZ
    Adv Anat Pathol; 2019 May; 26(3):215-219. PubMed ID: 30624253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilemmas and challenges in apolipoprotein L1 nephropathy research.
    Kruzel-Davila E; Skorecki K
    Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):77-86. PubMed ID: 30431460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Injury in APOL1-associated Kidney Disease.
    Ma L; Divers J; Freedman BI
    Transplantation; 2019 Mar; 103(3):487-492. PubMed ID: 30371607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOL1 nephropathy: from gene to mechanisms of kidney injury.
    Kruzel-Davila E; Wasser WG; Aviram S; Skorecki K
    Nephrol Dial Transplant; 2016 Mar; 31(3):349-58. PubMed ID: 25561578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene of the month:
    Raghubeer S; Pillay TS; Matsha TE
    J Clin Pathol; 2020 Aug; 73(8):441-443. PubMed ID: 32404472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry.
    Reidy KJ; Hjorten R; Parekh RS
    Curr Opin Pediatr; 2018 Apr; 30(2):252-259. PubMed ID: 29406442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A focus on the association of Apol1 with kidney disease in children.
    Ekulu PM; Nkoy AB; Adebayo OC; Kazadi OK; Aloni MN; Arcolino FO; Ngiyulu RM; Gini JE; Lepira FB; Van den Heuvel LP; Levtchenko EN
    Pediatr Nephrol; 2021 Apr; 36(4):777-788. PubMed ID: 32253519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOL1 Kidney Disease Risk Variants: An Evolving Landscape.
    Dummer PD; Limou S; Rosenberg AZ; Heymann J; Nelson G; Winkler CA; Kopp JB
    Semin Nephrol; 2015 May; 35(3):222-36. PubMed ID: 26215860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.